Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study

BACKGROUND: Recent studies on renin-angiotensin system (RAS) inhibitors have reported a reduced risk of Alzheimer’s disease (AD). Nevertheless, the effect of RAS inhibitor type and blood–brain barrier (BBB) permeability on the risk of AD is still unknown. OBJECTIVES: To assess the effects of RAS inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun Woo, Kim, Seungyeon, Jo, Youngkwon, Kim, Youjin, Ye, Byoung Seok, Yu, Yun Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025478/
https://www.ncbi.nlm.nih.gov/pubmed/36949774
http://dx.doi.org/10.3389/fnagi.2023.1137197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025478/
https://www.ncbi.nlm.nih.gov/pubmed/36949774
http://dx.doi.org/10.3389/fnagi.2023.1137197

Ejemplares similares